Clinical profile of parietal cell dysfunction in multiple gastric neuroendocrine tumors
Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S274
DOI: 10.1055/s-0044-1783341 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von M. Watanabe und 3 weiteren Autor:innen. Die Arbeit nennt 2 Literaturangaben.
Abstract (Originalsprache)
Aims
Parietal cell dysfunction (PCD), a novel disease, has been to cause multiple gastric neuroendocrine tumors (GNETs). In PCD, the proton pump in parietal cells doesn’t work well, causing a decrease in gastric acid secretion. This results in an increase in G cells in the pylorus, resulting in hypergastrinemia, which may induce a hyperplastic or neoplastic transformation of the enterochromaffin-like cells in the stomach fundus. Rindi et al. classified GNETs into three types. However, multiple GNETs caused by PCD do not fit into any of the existing types. Reports on PCD remain limited, and its diagnostic criteria remain unestablished. Our institution has managed several cases of PCD with multiple GNETs. This report aims to clarify the clinical characteristics of these cases.
Methods
The diagnosis of PCD was made if the patient fulfilled the following two criteria. First, achlorhydria should be documented through 24-hour intragastric pH monitoring. Second, minimal inflammation and atrophy should be present in the background fundic gland mucosa histologically, and on immunohistochemistry, unequivocal parietal cells should be negative for H + /K + -ATPase. Four cases met the above criteria in our hospital and an affiliated hospital. The clinical characteristics of these cases, including their endoscopic findings, were analyzed.
Results
The patients’ ages ranged from 37 to 50 years (mean: 42 years). All patients were asymptomatic and were referred to our hospital due to multiple gastric polyps. All patients were negative for anti- Helicobacter pylori antibodies. Three patients did not undergo eradication, but only one patient had a history of eradication. All patients denied intake of proton pump inhibitors and potassium-competitive acid blockers, and all patients had a serum gastrin level above 2,500 pg/mL. Three patients had no anti-parietal cell antibodies, while only one patient had low-positive titers (1:20). Lastly, all patients were negative for anti-intrinsic factor antibodies. Esophagogastroduodenoscopy revealed multiple reddish and yellowish subepithelial tumors in the body and fornix of the stomach, and the final diagnosis of NETs was obtained via biopsy. Two patients had more than 20 lesions each, and the other two cases had approximately 10 lesions each. Almost all lesions were less than 5 mm, with one or two lesions larger than 10 mm in two cases. No atrophy of the background mucosa was observed. Regular arrangement of collecting venules was observed, but somewhat indistinct, in three cases. White globe appearance (WGA) was also observed in the stomach fundus in all cases. Only one case was accompanied by sticky adherent dense mucus that was difficult to wash off. [ 1 ] [ 2 ]
Conclusions
PCD should be a differential diagnosis in patients presenting with multiple GNETs with an unknown etiology. Endoscopic findings caused by hypergastrinemia, such as WGA, may be helpful in the diagnosis of PCD. Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Watanabe, M., Hirasawa, T., Nakano, K., & Shiroma, S. (2024). Clinical profile of parietal cell dysfunction in multiple gastric neuroendocrine tumors. Endoscopy, 56(S 02 S 02), S274. https://doi.org/10.1055/s-0044-1783341
Vancouver
Watanabe M, Hirasawa T, Nakano K, Shiroma S. Clinical profile of parietal cell dysfunction in multiple gastric neuroendocrine tumors. Endoscopy. 2024;56(S 02 S 02):S274. doi:10.1055/s-0044-1783341
BibTeX
@article{Watanabe2024,
author = {Watanabe, M. and Hirasawa, T. and Nakano, K. and Shiroma, S.},
title = {Clinical profile of parietal cell dysfunction in multiple gastric neuroendocrine tumors},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {S 02 S 02},
pages = {S274},
doi = {10.1055/s-0044-1783341}
}
EUVIMED